1. Home
  2. ALDX vs ILLR Comparison

ALDX vs ILLR Comparison

Compare ALDX & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • ILLR
  • Stock Information
  • Founded
  • ALDX 2004
  • ILLR 2015
  • Country
  • ALDX United States
  • ILLR United States
  • Employees
  • ALDX N/A
  • ILLR N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • ILLR Investment Managers
  • Sector
  • ALDX Health Care
  • ILLR Finance
  • Exchange
  • ALDX Nasdaq
  • ILLR Nasdaq
  • Market Cap
  • ALDX 304.9M
  • ILLR 304.1M
  • IPO Year
  • ALDX 2014
  • ILLR N/A
  • Fundamental
  • Price
  • ALDX $6.58
  • ILLR $0.79
  • Analyst Decision
  • ALDX Strong Buy
  • ILLR
  • Analyst Count
  • ALDX 2
  • ILLR 0
  • Target Price
  • ALDX $10.00
  • ILLR N/A
  • AVG Volume (30 Days)
  • ALDX 666.8K
  • ILLR 567.6K
  • Earning Date
  • ALDX 05-01-2025
  • ILLR 03-25-2025
  • Dividend Yield
  • ALDX N/A
  • ILLR N/A
  • EPS Growth
  • ALDX N/A
  • ILLR N/A
  • EPS
  • ALDX N/A
  • ILLR N/A
  • Revenue
  • ALDX N/A
  • ILLR $45,244,000.00
  • Revenue This Year
  • ALDX N/A
  • ILLR N/A
  • Revenue Next Year
  • ALDX N/A
  • ILLR N/A
  • P/E Ratio
  • ALDX N/A
  • ILLR N/A
  • Revenue Growth
  • ALDX N/A
  • ILLR N/A
  • 52 Week Low
  • ALDX $2.75
  • ILLR $0.66
  • 52 Week High
  • ALDX $7.20
  • ILLR $8.86
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 53.63
  • ILLR N/A
  • Support Level
  • ALDX $6.22
  • ILLR N/A
  • Resistance Level
  • ALDX $6.87
  • ILLR N/A
  • Average True Range (ATR)
  • ALDX 0.46
  • ILLR 0.00
  • MACD
  • ALDX -0.03
  • ILLR 0.00
  • Stochastic Oscillator
  • ALDX 60.51
  • ILLR 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About ILLR Triller Group Inc. Common Stock

Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.

Share on Social Networks: